Mml Investors Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Mml Investors Services, LLC

  • $27.4 Billion
  • Q3 2024

A detailed history of Mml Investors Services, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 5,315 shares of REGN stock, worth $3.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,315
Previous 4,667 13.88%
Holding current value
$3.8 Million
Previous $4.91 Million 13.9%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$1024.09 - $1201.76 $663,610 - $778,740
648 Added 13.88%
5,315 $5.59 Million
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $650,035 - $788,395
-736 Reduced 13.62%
4,667 $4.91 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $158,873 - $174,829
-176 Reduced 3.15%
5,403 $5.2 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $1.08 Million - $1.22 Million
1,387 Added 33.09%
5,579 $4.9 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $1.17 Million - $1.43 Million
1,688 Added 67.41%
4,192 $3.45 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $244,310 - $289,792
349 Added 16.19%
2,504 $1.8 Million
Q1 2023

May 12, 2023
SELL
$680.49 - $826.97 $232,047 - $281,996
-341 Reduced 13.66%
2,155 $1.77 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $84,000 - $91,200
-119 Reduced 4.55%
2,496 $1.8 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $40,177 - $50,702
-70 Reduced 2.61%
2,615 $1.8 Million
Q2 2022

Aug 12, 2022
BUY
$548.35 - $738.84 $156,828 - $211,308
286 Added 11.92%
2,685 $1.59 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $723,070 - $848,592
-1,215 Reduced 33.62%
2,399 $1.68 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $311,957 - $385,136
574 Added 18.88%
3,614 $2.28 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $2.97 Million - $3.52 Million
-5,169 Reduced 62.97%
3,040 $1.84 Million
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $33,096 - $39,097
70 Added 0.86%
8,209 $4.59 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $2.08 Million - $2.56 Million
4,664 Added 134.22%
8,139 $3.85 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $74,136 - $94,236
-155 Reduced 4.27%
3,475 $1.68 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $85,525 - $103,338
157 Added 4.52%
3,630 $2.03 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $596,917 - $779,143
1,210 Added 53.47%
3,473 $2.17 Million
Q1 2020

May 14, 2020
SELL
$336.18 - $494.43 $576,884 - $848,441
-1,716 Reduced 43.13%
2,263 $1.11 Million
Q4 2019

Feb 11, 2020
SELL
$274.13 - $376.51 $16,447 - $22,590
-60 Reduced 1.49%
3,979 $1.49 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $381,203 - $443,835
-1,394 Reduced 25.66%
4,039 $1.12 Million
Q2 2019

Aug 13, 2019
SELL
$299.6 - $414.82 $35,952 - $49,778
-120 Reduced 2.16%
5,433 $1.7 Million
Q1 2019

May 10, 2019
SELL
$372.08 - $439.57 $610,583 - $721,334
-1,641 Reduced 22.81%
5,553 $2.28 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $141,044 - $169,276
-420 Reduced 5.52%
7,194 $2.69 Million
Q3 2018

Nov 07, 2018
BUY
$351.14 - $408.51 $547,778 - $637,275
1,560 Added 25.77%
7,614 $3.08 Million
Q2 2018

Aug 13, 2018
SELL
$284.6 - $344.99 $5,976 - $7,244
-21 Reduced 0.35%
6,054 $2.09 Million
Q1 2018

May 11, 2018
BUY
$315.82 - $393.78 $424,462 - $529,240
1,344 Added 28.41%
6,075 $2.09 Million
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $277,579 - $363,741
774 Added 19.56%
4,731 $1.78 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $1.71 Million - $1.99 Million
3,957
3,957 $1.77 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email